Core D: Biostatistics and Computational Analysis Core
核心 D:生物统计学和计算分析核心
基本信息
- 批准号:10731280
- 负责人:
- 金额:$ 14.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdjuvantAffinityArchivesB-LymphocytesBioinformaticsBiologicalBiological Response ModifiersBiometryBiostatistical MethodsBiostatistics CoreCommunitiesComputer AnalysisDataData AnalysesData ScienceData Science CoreDevelopmentDimensionsEarly identificationEnsureExperimental DesignsFAIR principlesGenerationsGenesGoalsHIVHIV envelope proteinHIV vaccineHuman ResourcesImmuneInfantKnowledgeLeadMediationMediatorMetabolic PathwayMethodologyMethodsModalityModelingMolecularMolecular ProfilingMultiomic DataOutputPathway AnalysisPathway interactionsPlasmaProteomeQuality ControlReproducibilityResearchResearch PersonnelResearch Project GrantsResearch SupportRoleStatistical Data InterpretationStatistical MethodsSumTimeVaccinationVaccine AdjuvantVaccine DesignVaccineeWorkanalytical toolcomputerized toolsdata integrationdata managementdesigndifferential expressionhigh dimensionalityhost microbiotaimmunoregulationinnovationinsightinteroperabilitylongitudinal analysismicrobial signaturemicrobiomemicrobiome analysismicrobiome signaturemultidimensional datamultimodalitymultiple omicsneutralizing antibodynovelprogramsquality assuranceresponsesingle-cell RNA sequencingstatisticstooltranscriptomicsvaccine responsevaccine strategyverification and validation
项目摘要
ABSTRACT - Biostatistics and Computational Analysis Core (BCAC)
The Biostatistics and Computational Analysis Core (BCAC) is a critical supporting core for the
proposed project. The BCAC will work closely with all project investigators to meet their
bioinformatic, statistical, and data science needs. By making data Findable, Accessible,
Interoperable and Reusable (FAIR), the BCAC will maximize the impact and optimize the path to
identifying high impact insights on the initial steps of the induction of bNAb precursors, and help
to address the knowledge gap whether vaccine adjuvant-induced innate responses impact bNAb
precursor development and affinity maturation which are expected to inform the development of
new targeted immunomodulatory approaches for HIV vaccine design.
The program will generate a suite of longitudinal data with a broad data types, including
transcriptomics, single cell (sc) RNA-sequencing, immunome analysis by CyTOF, proteome
analysis of soluble immune mediators in plasma, and bacterial presence/abundance in the gut.
Such rich data provides unprecedented opportunities to gain insights into innate responses, but
also creates analytically challenges to dissect underlying mechanisms of bNAb precursor
development, which are intricate with many factors interweaving with each other and jointly
impacting bNAb precursor development. The BCAC investigators are recognized experts in
biostatistics, data integration across multi-omics, and HIV research, which allows them to address
the challenges by providing state-of-the art expertise in a wide range of data science fields. The
core will ensure effective data management and data integration. More importantly, the core will
develop a suite of innovative approaches to integrate longitudinal immune, microbiome, and
molecular signatures to predict the development of bNAb precursors. The sum of the combined
results of Projects and Cores provided by the BACA in this Program will be greater than data
output that could be achieved by each Program component alone. By integrating the data
obtained in Project 1 with microbial signatures identified in Project 2, we expect to make more
precise prediction on bNAb precursor development, as defined by the B Cell Core.
摘要-生物统计学和计算分析核心(BCAC)
生物统计学和计算分析核心(BCAC)是生物统计学和计算分析的关键支持核心。
拟议项目。BCAC将与所有项目调查人员密切合作,
生物信息学、统计学和数据科学的需求。通过使数据可查找,可解释,
互操作和可重用(FAIR),BCAC将最大限度地发挥影响,并优化路径,
确定对诱导bNAb前体的初始步骤具有高度影响的见解,并帮助
解决疫苗免疫诱导的先天性应答是否影响bNAb的知识缺口
前体发展和亲和力成熟,预计将告知发展
HIV疫苗设计的新靶向免疫调节方法。
该程序将生成一套具有广泛数据类型的纵向数据,包括
转录组学,单细胞(sc)RNA测序,免疫组分析,蛋白质组
血浆中可溶性免疫介质和肠道中细菌存在/丰度的分析。
如此丰富的数据为深入了解先天反应提供了前所未有的机会,
也为剖析bNAb前体的潜在机制带来了分析上的挑战
发展是多种因素相互交织、共同作用的复杂过程
影响bNAb前体的发展。BCAC调查人员是公认的专家,
生物统计学,跨多组学的数据集成和艾滋病毒研究,这使他们能够解决
通过在广泛的数据科学领域提供最先进的专业知识来应对挑战。的
核心小组将确保有效的数据管理和数据整合。更重要的是,核心将
开发一套创新方法,整合纵向免疫,微生物组,
分子特征来预测bNAb前体的发展。组合的总和
巴卡在本计划中提供的项目和核心的结果将大于数据
每个计划组成部分单独可以实现的产出。通过整合数据
在项目1中获得了项目2中鉴定的微生物特征,我们希望能够获得更多
精确预测bNA B前体发育,如B细胞核心所定义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fei Zou其他文献
Fei Zou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fei Zou', 18)}}的其他基金
Robust Methods for Complex Trait Association Mapping
复杂性状关联映射的稳健方法
- 批准号:
7031501 - 财政年份:2006
- 资助金额:
$ 14.17万 - 项目类别:
Robust Methods for Complex Trait Association Mapping
复杂性状关联映射的稳健方法
- 批准号:
7391773 - 财政年份:2006
- 资助金额:
$ 14.17万 - 项目类别:
Robust Methods for Complex Trait Association Mapping
复杂性状关联映射的稳健方法
- 批准号:
7212146 - 财政年份:2006
- 资助金额:
$ 14.17万 - 项目类别:
Robust Methods for Complex Trait Mapping with Collaborative Cross
通过协作交叉进行复杂性状映射的稳健方法
- 批准号:
8538418 - 财政年份:2006
- 资助金额:
$ 14.17万 - 项目类别:
Robust Methods for Complex Trait Mapping with Collaborative Cross
通过协作交叉进行复杂性状映射的稳健方法
- 批准号:
8325543 - 财政年份:2006
- 资助金额:
$ 14.17万 - 项目类别:
Robust Methods for Complex Trait Mapping with Collaborative Cross
通过协作交叉进行复杂性状映射的稳健方法
- 批准号:
8711483 - 财政年份:2006
- 资助金额:
$ 14.17万 - 项目类别:
Robust Methods for Complex Trait Mapping with Collaborative Cross
通过协作交叉进行复杂性状映射的稳健方法
- 批准号:
8185739 - 财政年份:2006
- 资助金额:
$ 14.17万 - 项目类别:
Robust Methods for Complex Trait Association Mapping
复杂性状关联映射的稳健方法
- 批准号:
7590399 - 财政年份:2006
- 资助金额:
$ 14.17万 - 项目类别:
Statistical Analysis of RIX for Complex Traits
复杂性状 RIX 的统计分析
- 批准号:
6867324 - 财政年份:2004
- 资助金额:
$ 14.17万 - 项目类别:
Statistical Analysis of RIX for Complex Traits
复杂性状 RIX 的统计分析
- 批准号:
6758429 - 财政年份:2004
- 资助金额:
$ 14.17万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 14.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 14.17万 - 项目类别:
Studentship
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 14.17万 - 项目类别:
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 14.17万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 14.17万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 14.17万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 14.17万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 14.17万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 14.17万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 14.17万 - 项目类别:














{{item.name}}会员




